Mike Stratton, director of the Wellcome Trust Sanger Institute, has been knighted in the UK. Having founded the Cancer Genome Project at the Sanger Institute, Stratton lead the team that discovered mutations in the BRAF gene in malignant melanoma.
His research team in 2009 published data from the first full genome sequencing of two tumors, a lung cancer and a malignant melanoma. He also discovered the BRCA2 breast cancer susceptibility gene.
Genomic Health's shareholders earlier this month re-elected the company's board of directors. Members of the board will continue serving until the company's 2014 annual meeting. The re-elected board members are Kimberly Popovits, Felix Baker, Julian Baker, Fred Cohen, Samuel Colella, Ginger Graham, Randall Livingston, and Woodrow Myers.